BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10449431)

  • 1. Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases.
    Choukroun G; Hajjar R; Fry S; del Monte F; Haq S; Guerrero JL; Picard M; Rosenzweig A; Force T
    J Clin Invest; 1999 Aug; 104(4):391-8. PubMed ID: 10449431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy.
    Choukroun G; Hajjar R; Kyriakis JM; Bonventre JV; Rosenzweig A; Force T
    J Clin Invest; 1998 Oct; 102(7):1311-20. PubMed ID: 9769323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A farnesyltransferase inhibitor attenuates cardiac myocyte hypertrophy and gene expression.
    Calderone A; Abdelaziz N; Colombo F; Schreiber KL; Rindt H
    J Mol Cell Cardiol; 2000 Jun; 32(6):1127-40. PubMed ID: 10888263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
    Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
    J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
    Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
    Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cdk Inhibitor p16INK4a by adenovirus vector inhibits cardiac hypertrophy in vitro and in vivo: a novel strategy for the gene therapy of cardiac hypertrophy.
    Nozato T; Ito H; Watanabe M; Ono Y; Adachi S; Tanaka H; Hiroe M; Sunamori M; Marum F
    J Mol Cell Cardiol; 2001 Aug; 33(8):1493-504. PubMed ID: 11448137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch.
    Takeishi Y; Huang Q; Abe J; Glassman M; Che W; Lee JD; Kawakatsu H; Lawrence EG; Hoit BD; Berk BC; Walsh RA
    J Mol Cell Cardiol; 2001 Sep; 33(9):1637-48. PubMed ID: 11549343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKC mediates cyclic stretch-induced cardiac hypertrophy through Rho family GTPases and mitogen-activated protein kinases in cardiomyocytes.
    Pan J; Singh US; Takahashi T; Oka Y; Palm-Leis A; Herbelin BS; Baker KM
    J Cell Physiol; 2005 Feb; 202(2):536-53. PubMed ID: 15316932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy.
    Ueyama T; Kawashima S; Sakoda T; Rikitake Y; Ishida T; Kawai M; Yamashita T; Ishido S; Hotta H; Yokoyama M
    J Mol Cell Cardiol; 2000 Jun; 32(6):947-60. PubMed ID: 10888249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoenzyme-specific protein kinase C and c-Jun N-terminal kinase activation by electrically stimulated contraction of neonatal rat ventricular myocytes.
    Strait JB; Samarel AM
    J Mol Cell Cardiol; 2000 Aug; 32(8):1553-66. PubMed ID: 10900180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.
    Hayashida W; Kihara Y; Yasaka A; Inagaki K; Iwanaga Y; Sasayama S
    J Mol Cell Cardiol; 2001 Apr; 33(4):733-44. PubMed ID: 11273726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
    Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
    Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cardiac hypertrophic factor, neurotrophin-3, is paradoxically downregulated in cardiac hypertrophy.
    Kawaguchi-Manabe H; Ieda M; Kimura K; Manabe T; Miyatake S; Kanazawa H; Kawakami T; Ogawa S; Suematsu M; Fukuda K
    Life Sci; 2007 Jul; 81(5):385-92. PubMed ID: 17628607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant-negative c-Jun inhibits rat cardiac hypertrophy induced by angiotensin II and hypertension.
    Kim-Mitsuyama S; Izumi Y; Izumiya Y; Namba M; Yoshida K; Wake R; Yoshiyama M; Iwao H
    Gene Ther; 2006 Feb; 13(4):348-55. PubMed ID: 16251994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
    Molkentin JD
    Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of KR-31378, a novel ATP-sensitive potassium channel activator, on hypertrophy of H9c2 cells and on cardiac dysfunction in rats with congestive heart failure.
    Hwang GS; Oh KS; Koo HN; Seo HW; You KH; Lee BH
    Eur J Pharmacol; 2006 Jul; 540(1-3):131-8. PubMed ID: 16729997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
    Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I
    Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells.
    Wang Y; Su B; Sah VP; Brown JH; Han J; Chien KR
    J Biol Chem; 1998 Mar; 273(10):5423-6. PubMed ID: 9488659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes.
    Nakaoka Y; Nishida K; Fujio Y; Izumi M; Terai K; Oshima Y; Sugiyama S; Matsuda S; Koyasu S; Yamauchi-Takihara K; Hirano T; Kawase I; Hirota H
    Circ Res; 2003 Aug; 93(3):221-9. PubMed ID: 12855672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.